Biotage AB (publ) (BIOT.ST)
SEK 158.8
(1.73%)
SEK 158.8
(1.73%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | 1.14 Billion SEK | 21.2% |
| 2022 | 948 Million SEK | 25.56% |
| 2021 | 755 Million SEK | 13.24% |
| 2020 | 666.72 Million SEK | -2.73% |
| 2019 | 685.41 Million SEK | 23.14% |
| 2018 | 556.62 Million SEK | 21.89% |
| 2017 | 456.66 Million SEK | 18.36% |
| 2016 | 385.81 Million SEK | 12.62% |
| 2015 | 342.56 Million SEK | 28.34% |
| 2014 | 266.91 Million SEK | 6.95% |
| 2013 | 249.58 Million SEK | -8.05% |
| 2012 | 271.43 Million SEK | 10.21% |
| 2011 | 246.28 Million SEK | -3.9% |
| 2010 | 256.26 Million SEK | 13.85% |
| 2009 | 225.09 Million SEK | 0.29% |
| 2008 | 224.45 Million SEK | -27.55% |
| 2007 | 309.79 Million SEK | -5.38% |
| 2006 | 327.42 Million SEK | 42.33% |
| 2005 | 230.04 Million SEK | 5.4% |
| 2004 | 218.25 Million SEK | 108.06% |
| 2003 | 104.89 Million SEK | 56.17% |
| 2002 | 67.16 Million SEK | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q3 | 303 Million SEK | -6.48% |
| 2024 Q2 | 324 Million SEK | 6.93% |
| 2024 Q1 | 303 Million SEK | -22.9% |
| 2023 Q1 | 220 Million SEK | -2.65% |
| 2023 FY | 1.01 Billion SEK | 6.86% |
| 2023 Q3 | 282 Million SEK | 11.02% |
| 2023 Q2 | 254 Million SEK | 15.45% |
| 2023 Q4 | 393 Million SEK | 39.36% |
| 2022 Q3 | 241 Million SEK | 0.0% |
| 2022 FY | 948 Million SEK | 25.56% |
| 2022 Q1 | 241 Million SEK | 13.68% |
| 2022 Q2 | 241 Million SEK | 0.0% |
| 2022 Q4 | 226 Million SEK | -6.22% |
| 2021 FY | 755 Million SEK | 13.24% |
| 2021 Q1 | 177.46 Million SEK | -0.67% |
| 2021 Q2 | 182.17 Million SEK | 2.66% |
| 2021 Q4 | 212 Million SEK | 15.85% |
| 2021 Q3 | 183 Million SEK | 0.45% |
| 2020 Q1 | 173.41 Million SEK | -3.06% |
| 2020 FY | 666.72 Million SEK | -2.73% |
| 2020 Q4 | 178.65 Million SEK | 11.28% |
| 2020 Q3 | 160.54 Million SEK | 4.18% |
| 2020 Q2 | 154.1 Million SEK | -11.13% |
| 2019 FY | 685.41 Million SEK | 23.14% |
| 2019 Q3 | 177.63 Million SEK | 1.0% |
| 2019 Q2 | 175.87 Million SEK | 14.94% |
| 2019 Q1 | 153.01 Million SEK | 6.23% |
| 2019 Q4 | 178.88 Million SEK | 0.71% |
| 2018 Q1 | 126.8 Million SEK | 9.68% |
| 2018 FY | 556.62 Million SEK | 21.89% |
| 2018 Q2 | 144.39 Million SEK | 13.87% |
| 2018 Q3 | 141.38 Million SEK | -2.08% |
| 2018 Q4 | 144.04 Million SEK | 1.87% |
| 2017 Q3 | 107.24 Million SEK | -11.4% |
| 2017 Q1 | 112.75 Million SEK | 6.5% |
| 2017 Q2 | 121.04 Million SEK | 7.35% |
| 2017 FY | 456.66 Million SEK | 18.36% |
| 2017 Q4 | 115.61 Million SEK | 7.8% |
| 2016 Q4 | 105.87 Million SEK | 10.08% |
| 2016 FY | 385.81 Million SEK | 12.62% |
| 2016 Q2 | 93.09 Million SEK | 2.67% |
| 2016 Q1 | 90.66 Million SEK | -3.86% |
| 2016 Q3 | 96.18 Million SEK | 3.32% |
| 2015 FY | 342.56 Million SEK | 28.34% |
| 2015 Q4 | 94.3 Million SEK | 12.49% |
| 2015 Q3 | 83.83 Million SEK | -0.73% |
| 2015 Q2 | 84.45 Million SEK | 5.59% |
| 2015 Q1 | 79.97 Million SEK | 6.77% |
| 2014 FY | 266.91 Million SEK | 6.95% |
| 2014 Q2 | 65.65 Million SEK | 6.43% |
| 2014 Q3 | 64.65 Million SEK | -1.53% |
| 2014 Q1 | 61.69 Million SEK | -7.74% |
| 2014 Q4 | 74.9 Million SEK | 15.85% |
| 2013 Q3 | 58.56 Million SEK | -11.07% |
| 2013 FY | 249.58 Million SEK | -8.05% |
| 2013 Q1 | 58.28 Million SEK | -14.43% |
| 2013 Q2 | 65.85 Million SEK | 12.98% |
| 2013 Q4 | 66.87 Million SEK | 14.18% |
| 2012 Q4 | 68.11 Million SEK | 5.44% |
| 2012 Q3 | 64.6 Million SEK | -8.23% |
| 2012 Q1 | 68.31 Million SEK | 6.97% |
| 2012 Q2 | 70.39 Million SEK | 3.05% |
| 2012 FY | 271.43 Million SEK | 10.21% |
| 2011 FY | 246.28 Million SEK | -3.9% |
| 2011 Q2 | 57.89 Million SEK | -8.07% |
| 2011 Q3 | 61.55 Million SEK | 6.32% |
| 2011 Q4 | 63.86 Million SEK | 3.75% |
| 2011 Q1 | 62.97 Million SEK | -12.11% |
| 2010 Q3 | 64.93 Million SEK | 6.81% |
| 2010 Q2 | 60.79 Million SEK | 3.26% |
| 2010 Q1 | 58.88 Million SEK | 9.3% |
| 2010 FY | 256.26 Million SEK | 13.85% |
| 2010 Q4 | 71.64 Million SEK | 10.33% |
| 2009 Q2 | 63.4 Million SEK | 11.95% |
| 2009 Q4 | 53.87 Million SEK | 5.27% |
| 2009 Q1 | 56.64 Million SEK | 0.0% |
| 2009 FY | 225.09 Million SEK | 0.29% |
| 2009 Q3 | 51.17 Million SEK | -19.29% |
| 2008 FY | 224.45 Million SEK | -27.55% |
| 2007 FY | 309.79 Million SEK | -5.38% |
| 2006 FY | 327.42 Million SEK | 42.33% |
| 2005 FY | 230.04 Million SEK | 5.4% |
| 2004 FY | 218.25 Million SEK | 108.06% |
| 2003 FY | 104.89 Million SEK | 56.17% |
| 2002 FY | 67.16 Million SEK | 0.0% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| AddLife AB (publ) | 2.77 Billion SEK | 58.565% |
| Bonesupport Holding AB (publ) | 533.12 Million SEK | -115.522% |
| Doxa AB (publ) | 9.9 Million SEK | -11506.061% |
| Elekta AB (publ) | 6.77 Billion SEK | 83.046% |
| iZafe Group AB (publ) | 293 Thousand SEK | -392050.171% |
| Ortivus AB (publ) | 30.84 Million SEK | -3625.56% |
| Ortivus AB (publ) | 30.84 Million SEK | -3625.56% |
| Q-linea AB (publ) | 995 Thousand SEK | -115377.387% |
| S2Medical AB (publ) | 5.03 Million SEK | -22711.193% |
| Synsam AB (publ) | 617 Million SEK | -86.224% |